INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $2,407,000 | +71.8% | 87,405 | 0.0% | 0.05% | +6.8% |
Q1 2020 | $1,401,000 | -93.8% | 87,405 | -87.9% | 0.04% | -97.8% |
Q3 2017 | $22,556,000 | -51.6% | 722,714 | -75.8% | 2.04% | -58.1% |
Q3 2013 | $46,570,000 | +60.0% | 2,983,319 | +22.6% | 4.86% | +25.9% |
Q2 2013 | $29,102,000 | – | 2,433,319 | – | 3.86% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,533,883 | $44,590,000 | 16.02% |
Foresite Capital Management II, LLC | 919,436 | $26,728,000 | 12.07% |
NEXTHERA CAPITAL LP | 284,263 | $8,264,000 | 10.03% |
Palo Alto Investors LP | 7,653,617 | $222,491,000 | 9.28% |
Asymmetry Capital Management, L.P. | 154,887 | $4,503,000 | 7.52% |
ACUTA CAPITAL PARTNERS, LLC | 370,000 | $10,756,000 | 5.11% |
Vivo Capital, LLC | 1,170,290 | $34,020,000 | 3.39% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 110,000 | $3,198,000 | 1.18% |
Islet Management, LP | 350,000 | $10,175,000 | 1.18% |
EMERALD ADVISERS, LLC | 921,527 | $26,789,000 | 1.09% |